Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/235840
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Designing functionally versatile, highly immunogenic peptide-based multiepitopic vaccines against foot-and-mouth disease virus

AutorDefaus, Sira; Rodríguez Pulido, Miguel Ramón CSIC ORCID; Sobrino Castelló, Francisco CSIC ORCID; Bustos, Maria José; León, Patricia de CSIC ORCID; Cañas-Arranz, Rodrigo; Forner, Mar; Blanco Lavilla, Esther CSIC ORCID; Andreu, David
Palabras clavePeptide-based vaccines
Foot-and-mouth disease virus
Multivalency
Click chemistry
Swine host
Fecha de publicación22-jul-2020
CitaciónVaccines 8 (2020)
ResumenA broadly protective and biosafe vaccine against foot-and-mouth disease virus (FMDV) remains an unmet need in the animal health sector. We have previously reported solid protection against serotype O FMDV a orded by dendrimeric peptide structures harboring virus-specific B- and T-cell epitopes, and also shown such type of multivalent presentations to be advantageous over simple B-T-epitope linear juxtaposition. Chemically, our vaccine platforms are modular constructions readily made from specified B- and T-cell epitope precursor peptides that are conjugated in solution. With the aim of developing an improved version of our formulations to be used for on-demand vaccine applications, we evaluate in this study a novel design for epitope presentation to the immune system based on a multiple antigen peptide (MAP) containing six immunologically relevant motifs arranged in dendrimeric fashion (named B2T-TB2). Interestingly, two B2T units fused tail-to-tail into a single homodimer platform elicited higher B- and T-cell specific responses than former candidates, with immunization scores remaining stable even after 4 months. Moreover, this macromolecular assembly shows consistent immune response in swine, the natural FMDV host, at reduced dose. Thus, our versatile, immunogenic prototype can find application in the development of peptide-based vaccine candidates for various therapeutic uses using safer and more ecacious vaccination regimens
Versión del editorhttp://dx.doi.org/10.3390/vaccines8030406
URIhttp://hdl.handle.net/10261/235840
DOI10.3390/vaccines8030406
Identificadoresdoi: 10.3390/vaccines8030406
issn: 2076-393X
Aparece en las colecciones: (CBM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
SobrinoF_DesigningFunctionally.pdf562,47 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

6
checked on 18-abr-2024

SCOPUSTM   
Citations

6
checked on 21-abr-2024

WEB OF SCIENCETM
Citations

6
checked on 22-feb-2024

Page view(s)

71
checked on 26-abr-2024

Download(s)

90
checked on 26-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons